EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Proteoglycans as Molecular Regulators of Bone Metastasis: Extracellular Matrix Remodeling, Tumor–Bone Crosstalk, Dormancy, and Therapeutic Opportunities

Zoila Mora Guzmán, Ibzan Jahzeel Salvador Ibarra iD, Patricia Juárez iD, Anahí Jobeth Borrás Enríquez iD, Edmar de Jésús Díaz García, Hector Alejandro Cabrera-Fuentes iD, María Teresa Hernández-Huerta iD

Biomolecules · 16.07.2026 · 16 (7) · 1039

DOI: 10.3390/biom16071039 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 16.07.2026. Verfasst von Zoila Mora Guzmán und 6 weiteren Autor:innen. Beteiligte Einrichtung: Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Facultad de Medicina y Cirugía, Universidad Autónoma "Benito Juárez" de Oaxaca…. Hauptthemen laut MEDLINE: Bone Neoplasms, Extracellular Matrix, Proteoglycans. Die Arbeit nennt 237 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bone metastasis is a frequent and debilitating complication of advanced cancer, particularly in breast and prostate cancer, and is driven by complex interactions among tumor cells, bone-resident cells, immune populations, vascular components, and the extracellular matrix. Within this specialized microenvironment, proteoglycans have emerged as key molecular regulators of tumor–bone crosstalk, matrix remodeling, metastatic niche formation, dormancy, and therapeutic resistance.

Methods

We conducted a narrative review using targeted searches of PubMed and Google Scholar for studies published through 31 May 2026. Search terms included combinations of proteoglycan- and glycosaminoglycan-related concepts, including “proteoglycans,” “glycosaminoglycans,” “heparan sulfate proteoglycans,” “hyaluronan,” “heparanase,” “syndecans,” “glypicans,” “perlecan/HSPG2,” “versican,” and “decorin,” with disease- and process-related terms such as “bone metastasis,” “extracellular matrix,” “tumor–bone crosstalk,” “breast cancer,” “prostate cancer,” “metastatic niche,” “osteolytic metastasis,” “osteoblastic metastasis,” “dormancy,” “reactivation,” “immune regulation,” and “therapy resistance.” Original studies, reviews, and translational reports were selected according to their relevance to cell-surface, pericellular, and extracellular proteoglycans in bone metastatic progression.

Results

Proteoglycans and associated GAG/ECM axes are implicated in multiple processes involved in skeletal metastasis, including growth factor availability, extracellular matrix organization, osteolytic and osteoblastic niche formation, angiogenesis, immune evasion, metastatic dormancy, reactivation, and therapy resistance. These functions are highly context-dependent and are influenced by proteoglycan localization, core protein structure, glycosaminoglycan composition, sulfation patterns, proteolytic processing, and cellular source.

Conclusions

Proteoglycans represent critical molecular nodes in the bone metastatic microenvironment and hold potential as biomarkers, therapeutic targets, and tools for stratifying metastatic niche heterogeneity. Their clinical translation will require validation in human bone metastasis samples, improved models that reproduce the mineralized and immune-rich bone niche, and a clearer distinction between causal mechanisms and correlative associations. Future studies should integrate matrisome profiling, spatial proteomics, single-cell and spatial transcriptomics, glycosaminoglycan omics, degradomics, and three-dimensional bone niche models to define actionable proteoglycan-dependent mechanisms and improve therapeutic targeting of metastatic bone disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsExtracellular MatrixProteoglycansHumansProstatic NeoplasmsMaleAnimalsTumor MicroenvironmentBreast Neoplasms

Stichwörter der Autor:innen

bone metastasisbreast cancerdecorinextracellular matrixhyaluronanmetastatic nicheperlecanprostate cancerproteoglycansversican

Substanzen

Proteoglycans

Autor:innen und Institutionen

  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Facultad de Medicina y Cirugía, Universidad Autónoma "Benito Juárez" de Oaxaca, Oaxaca 68020, Mexico.
  • Centro de Investigación Facultad de Medicina UNAM-UABJO, Facultad de Medicina y Cirugía, Universidad Autónoma "Benito Juárez" de Oaxaca, Oaxaca 68020, Mexico.
  • Instituto Mexicano del Seguro Social, Hospital General de Zona con Medicina Familiar No. 18, Torreón 27220, Mexico.
  • Biomedical Innovation Department, Center for Scientific Research and Higher Education at Ensenada, Ensenada 22860, Mexico.
  • División de Estudios de Posgrado e Investigación, Tecnológico Nacional de México/Instituto Tecnológico de Tuxtla Gutiérrez, Tuxtla Gutiérrez 29050, Mexico.
  • R&D Group, Vice Presidency for Scientific Research and Innovation, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.

ORCID-Profile: Ibzan Jahzeel Salvador Ibarra, Patricia Juárez, Anahí Jobeth Borrás Enríquez, Hector Alejandro Cabrera-Fuentes, María Teresa Hernández-Huerta

Zitieren

APA

Mora Guzmán, Z., Salvador Ibarra, I. J., Juárez, P., Borrás Enríquez, A. J., Díaz García, E. J., Cabrera-Fuentes, H. A., & Hernández-Huerta, M. T. (2026). Proteoglycans as Molecular Regulators of Bone Metastasis: Extracellular Matrix Remodeling, Tumor–Bone Crosstalk, Dormancy, and Therapeutic Opportunities. Biomolecules, 16(7), 1039. https://doi.org/10.3390/biom16071039

Vancouver

Mora Guzmán Z, Salvador Ibarra IJ, Juárez P, Borrás Enríquez AJ, Díaz García EJ, Cabrera-Fuentes HA, et al. Proteoglycans as Molecular Regulators of Bone Metastasis: Extracellular Matrix Remodeling, Tumor–Bone Crosstalk, Dormancy, and Therapeutic Opportunities. Biomolecules. 2026;16(7):1039. doi:10.3390/biom16071039

BibTeX
@article{MoraGuzmn2026,
  author = {Mora Guzmán, Zoila and Salvador Ibarra, Ibzan Jahzeel and Juárez, Patricia and Borrás Enríquez, Anahí Jobeth and Díaz García, Edmar de Jésús and Cabrera-Fuentes, Hector Alejandro and Hernández-Huerta, María Teresa},
  title = {Proteoglycans as Molecular Regulators of Bone Metastasis: Extracellular Matrix Remodeling, Tumor–Bone Crosstalk, Dormancy, and Therapeutic Opportunities},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {1039},
  doi = {10.3390/biom16071039}
}
Kostenlos starten →